News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection



10/2/2006 10:21:00 AM

Tokyo, Oct 2, 2006 (JCN) - Sankyo Co., Ltd., a wholly owned subsidiary of Daiichi Sankyo Company, Limited, has filed an application for an additional indication for Fentanyl Injection 0.1 mg and 0.25 mg (generic name: fentanyl citrate) with the Ministry of Health, Labour and Welfare.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES